Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells

ACS Applied Materials and Interfaces

Volumn 7, Issue 4, 2015, Pages 2269-2279

  Subia, Bano ^a   Dey, Tuli ^a   Sharma, Shaily ^a   Kundu, Subhas C ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

3D in vitro model; bone metastasis; coculture; drug delivery; silk fibroin

Indexed keywords

3D MODELING; ANIMALS; BONE; CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; DISEASES; DRUG DELIVERY; MOLECULES; PHOSPHATASES; POPULATION STATISTICS; SCAFFOLDS (BIOLOGY);

ANTI-CANCER DRUG DELIVERY; BONE METASTASIS; COCULTURE; DRUG DELIVERY SYSTEM; IN-VITRO MODELS; OSTEOBLAST-LIKE CELLS; SILK FIBROIN; VASCULAR ENDOTHELIAL GROWTH FACTOR;

TARGETED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; DOXORUBICIN; FIBROIN; NANOPARTICLE;

ANIMAL; BOMBYX; BONE NEOPLASMS; BREAST NEOPLASMS; CHEMISTRY; COCULTURE; CYTOLOGY; DEVICES; DRUG DELIVERY SYSTEM; DRUG EFFECTS; EVALUATION STUDY; FEMALE; HUMAN; METASTASIS; OSTEOBLAST; PATHOLOGY; PROCEDURES; SECONDARY; TISSUE SCAFFOLD; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BOMBYX; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; FIBROINS; HUMANS; NANOPARTICLES; NEOPLASM METASTASIS; OSTEOBLASTS; TISSUE SCAFFOLDS;

EID: 84922424405     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/am506094c     Document Type: Article

References (56)

1. She, W.; Li, N.; Luo, K.; Guo, C.; Wang, G.; Geng, Y.; Gu, Z. Dendronized Heparin Doxorubicin Conjugate Based Nanoparticle as pH-Responsive Drug Delivery System for Cancer Therapy Biomaterials 2013, 34, 2252-2264
2. Huang, C. W.; Lin, F. M.; Chang, T. H.; Liao, K. W.; Huang, H. D. Identifying Cancer Highly-Expressed Membrane Receptors for Targeted Drug Delivery Int. J. Bioinform. Res. Appl. 2012, 8, 192-209
3. Subia, B.; Kundu, S. C. Drug Loading and Release on Tumor Cells using Silk fibroin-Albumin Nanoparticles as Carriers Nanotechnology 2013, 24, 035103
4. Zwicke, G. L.; Mansoori, G. Ali.; Jeffery, C. J. Utilizing the Folate Receptors for Active Targeting of Cancer Nanotherpautics Nano Rev. 2012, 3, PMC3521101
5. Yang, S. J.; Lin, F. H.; Tsai, K. C.; Wei, M. F.; Tsai, H. M.; Wong, J. M.; Shieh, M. Folic Acid-Conjugated Chitosan Nanoparticles Enhanced Protoporphyrin IX Accumulation in Colorectal Cancer Cells J. Bioconjugate Chem. 2010, 21, 667-689
6. Zhang, Y.; Hong, H.; Myklejord, D. V.; Cai, W. Molecular Imaging with SERS-Active Nanoparticles Small 2011, 7, 3261-3269
7. Provenzale, J. M.; Silva, G. A. Use of Nanoparticles for Central Nervous System Imaging and Therapy A. J. Nanotechnol. 2009, 30, 1293-1301
8. Song, H.; Su, C.; Cui, W.; Zhu, B.; Liu, L.; Chen, Z.; Zhao, L. Folic acid-Chitosan Conjugated Nanoparticles for Improving Tumor-Targeted Drug Delivery BioMed. Res. Int. 2013, 723, 158-1564
9. Du, C.; Deng, D.; Shan, L.; Wan, S.; Cao, J.; Tian, J.; Gu, Y. A pH-Sensitive Doxorubicin Prodrug Based on Folate-Conjugated BSA for Tumor-Targeted Drug Delivery Biomaterials 2013, 34, 3087-3097
10. Subia, B.; Chandra, S.; Talukdar, S.; Kundu, S. C. Folate Conjugated Silk Fibroin Nanocarriers for Targeted Drug Delivery Integr. Biol. 2014, 6, 203-214
11. Gao, W.; Xiang, B.; Meng, T. T.; Liu, F.; Qi, X. R. Chemotherapeutic Drug Delivery to Cancer Cells Using a Combination of Folate Targeting and Tumor Microenvironment-Sensitive Polypeptides Biomaterials 2013, 34, 4137-4149
12. Shinoda, T.; Takagi, A.; Maeda, A.; Kagatani, S.; Konno, Y.; Hashida, M. In Vivo Fate of Folate-BSA in Non-Tumor and Tumor Bearing Mice J. Pharm. Sci. 1998, 87, 1521-1526
13. Yoo, H. S.; Park, T. G. Folate Receptor Targeted Biodegradable Polymeric Doxorubicin Micelles J. Controlled Release 2004, 96, 273-283
14. Lee, E. S.; Na, K.; Bae, Y. H. Doxorubicin Loaded pH-Sensitive Polymeric Micelles for Reversal of Resistant MCF-7 Tumor J. Controlled Release 2005, 103, 405-418
15. Paulos, C. M.; Reddy, J. A.; Leamon, C. P.; Turk, M. J.; Low, P. S. Ligand Binding and Kinetics of Folate Receptor Recycling In Vivo: Impact on Receptor-Mediated Drug Delivery Mol. Pharmacol. 2004, 66, 1406-1414
16. Xu, S.; Olenyuk, B. Z.; Okamoto, C. T.; Hamm-Alvarez, S. F. Targeting Receptor Mediated Endocytosis Pathways with Nanoparticles: Rationale and Advances Adv. Drug Delivery Rev. 2013, 65, 121-138
17. Szot, C. S.; Buchanan, C. F.; Freeman, J. W.; Rylander, M. N. 3D In Vitro Bioengineered Tumors Based on Collagen I Hydrogels Biomaterials 2011, 32, 7905-7912
18. Birgersdotter, A.; Sandberg, R.; Ernberg, I. Gene Expression Perturbation In Vitro -A Growing Case for Three Dimensional (3D) Culture Systems Semin. Cancer Biol. 2005, 15, 405-412
19. Weigelt, B.; Bissell, M. J. Unraveling The Micro-Environmental Influences on The Normal Mammary Gland and Breast Cancer Semin. Cancer Biol. 2008, 18, 311-321
20. Kim, J. B. Three-Dimensional Tissue Culture Models in Cancer Biology Semin. Cancer Biol. 2005, 15, 365-377
21. Sieh, S.; Taubenberger, A. V.; Lehman, M. L.; Clements, J. A.; Nelson, C. C.; Hutmacher, D. W. Paracrine Interactions Between LnCAP Prostate Cancer Cells and Bioengineered Bone in 3D In Vitro Culture Reflect Molecular Changes During Bone Metastasis Bone 2014, S8, 756-782
22. Nyga, A.; Cheema, U.; Loizidou, M. 3D Tumour Models: Novel In Vitro Approaches to Cancer Studies J. Cell Commun. Signal. 2013, 5, 239-248
23. Marlow, R.; Honeth, G.; Lombardi, S.; Cariati, M.; Hessey, S. M.; Pipili, A.; Mariotti, V.; Buchupalli, B.; Foster, K.; Bonnet, D.; Grigoriadis, A.; Purushotham, A.; Tutt, A.; Dontu, G. A Novel Model of Dormancy for Bone Metastatic Breast Cancer Cells Cancer Res. 2013, 73, 6886-6899
24. Zhang, M.; Boughton, P.; Rose, B.; Lee, S.; Hong, M. A. The Use of Porous Scaffold as a Tumor Model Int. J. Biomater. 2013, 396056-396065
25. Talukdar, S.; Kundu, S. C. Engineered 3D Silk-Based Metastasis Models: Interactions Between Human Breast Adenocarcinoma, Mesenchymal Stem Cells and Osteoblast-Like Cells Adv. Funct. Mater. 2013, 23, 5249-5260
26. Mandal, B. B.; Kundu, S. C. Non-Bioengineered Silk Gland Fibroin Protein: Characterization and Evaluation of Matrices for Potential Tissue Engineering Applications Biotechnol. Bioeng. 2008, 100, 1237-1250
27. Talukdar, S.; Mandal, M.; Hutmacher, D. W.; Russell, P. J.; Soekmadji, C.; Kundu, S. C. Engineered Silk Fibroin Protein 3D Matrices for In Vitro Tumor Model Biomaterials 2011, 32, 2149-2159
28. Baker, E. L.; Lu, J.; Yu, D.; Bonnecaze, R. T.; Zaman, M. H. Cancer Cell Migration: Integrated roles of Matrix Mechanism and Transformation Potential Biophys. J. 2010, 99, e20355
29. McKnight, A. L.; Kugel, J. L.; Rossman, P. J.; Manduca, A.; Hartmann, L. C.; Ehman, R. L. MRI Elastography of Breast Cancer Preliminary Results Am. J. Roentgenol. 2002, 178, 1411-1417
30. Talukdar, S.; Kundu, S. C. Non Mulberry Silk Fibroin Protein Based In Vitro Tumor Model for Evaluation of Anticancer Drug Delivery Adv. Funct. Mater. 2012, 22, 4778-4788
31. Mandal, B. B.; Kundu, S. C. Non Mulberry Silk Gland Fibroin Protein 3D Scaffolds for Enhanced Differentiation of Human Mesenchymal Stem Cells into Osteocytes Acta Biomater. 2009, 5, 2579-2590
32. Kleinman, H. K.; Martin, G. R. Matrigel: Basement Membrane Matrix with Biological Activity Semin. Cancer Biol. 2005, 15, 378-386
33. Zhao, Y.; Yao, R.; Ouyang, L.; Ding, H.; Zhang, T.; Zhang, K.; Cheng, S.; Sun, W. Three-Dimensional Printing of HeLa Cells for Cervical Tumor Model In Vitro Biofabrication 2014, 6, 035001
34. Fischbach, C.; Chen, R.; Matsumoto, T.; Schmelzle, T.; Brugge, J. S.; Polverini, P. J.; Mooney, D. J. Engineering Tumors with 3D Scaffolds Nat. Methods 2007, 4, 855-860
35. Ma, L.; Barker, J.; Zhou, C.; Li, W.; Zhang, J.; Lin, B.; Foltz, G.; Küblbeck, J.; Honkakoski, P. Towards Personalized Medicine with A Three-Dimensional Micro-Scale Perfusion-Based Two-Chamber Tissue Model System Biomaterials 2012, 33, 4353-4361
36. Sieh, S.; Taubenberger, A. V.; Lehman, M. L.; Clements, J. A.; Nelson, C. C.; Hutmacher, D. W. Paracrine Interactions Between LnCAP Prostate Cancer Cells and Bioengineered Bone in 3D In Vitro Culture Reflect Molecular Changes During Bone Metastasis Bone 2014, 63, 121-131
37. Lescarbeau, R. M.; Seib, F. P.; Prewitz, M.; Werner, C.; Kaplan, D.L. In Vitro Model of Metastasis to Bone Marrow Mediates Prostate Cancer Castration Resistant Growth through Paracrine and Extracellular Matrix Factors PLoS One 2012, 7, e40372
38. Horning, J. L.; Sahoo, S. K.; Vijayaraghavalu, S.; Dimitrijevic, S.; Vasir, J. K.; Jain, T. K.; Panda, A. K.; Labhasetwar, L. 3D Tumor Model for In Vitro Evaluation of Anticancer Drugs Mol. Pharmaceutics 2008, 5, 849-862
39. Talukdar, S.; Kundu, S. C. Engineered 3D Silk-Based Metastasis Models: Interactions Between Human Breast Adenocarcinoma, Mesenchymal Stem Cells and Osteoblast-Like Cells Adv. Funct. Mater. 2013, 23, 5249-5260
40. Dhiman, H. K.; Ray, A. R.; Panda, A. K. Three-Dimensional Chitosan Scaffold-Based MCF-7 Cell Culture for the Determination of the Cytotoxicity of Tamoxifen Biomaterials 2005, 26, 979-986
41. Dunne, L. W.; Huang, Z.; Meng, W.; Fan, X.; Zhang, N.; Zhang, Q.; An, Z. Human Decellularised Adipose Tissue Scaffold as a Model for Breast Cancer Cell Growth and Drug Treatments Biomaterials 2014, 35, 4940-4990
42. Shin, C. S.; Kwak, B.; Han, B.; Park, K. Development of an In Vitro 3D Tumor Model to Study Therapeutic Efficiency of an Anticancer Drug Mol. Pharmaceutics 2013, 10, 102-140
43. Talukdar, S.; Kundu, S. C. A Non-Mulberry Silk Fibroin Protein Based 3D In Vitro Tumor Model for Evaluation of Anticancer Drug Activity Adv. Funct. Mater. 2012, 22, 4778-4788
44. Gupta, V.; Mun, G. H.; Choi, B.; Aseh, A.; Mildred, L.; Patel, A.; Zhang, Q.; Price, J. E.; Chang, D.; Robb, G.; Mathur, A. B. Repair and Reconstruction of a Resected Tumor Defectusing a Composite of Tissue Flap-Nanotherapeutic-Silk Fibroin and Chitosan Scaffold Ann. Biomed. Eng. 2011, 39, 2374-2387
45. El-Dakdouki, M. H.; Xia, J.; Zhu, D. C.; Kavunja, H.; Grieshaber, J.; OReilly, S.; McCormick, J. J.; Huang, X. Assessing the In Vivo Efficacy of Doxorubicin Loaded Hyaluronan Nanoparticles ACS Appl. Mater. Interfaces 2014, 6 (1) 697-705
46. Chen, M.; Le, D.; Hein, S.; Li, P.; Nygaard, J. V.; Kassem, M.; Kjems, J.; Besenbacher, F.; Bünger, C. Fabrication and Characterization of a Rapid Prototyped Tissue Engineering Scaffold with Embedded Multicomponent Matrix for Controlled Drug Release Int. J. Nanomed. 2012, 7, 4285-4297
47. Ricketts, K. P. M.; Cheema, U.; Nyga, A.; Castoldi, A.; Guazzoni, C.; Magdeldin, T.; Emberton, M.; Gibson, A. P.; Royle, G. J.; Loizidou, M. A 3D In Vitro Cancer Model as a Platform for Nanoparticle Uptake and Imaging Investigations Small 2014, 10.1002/smll.201400194
48. Godugu, C.; Patel, A. R.; Desai, U.; Andey, T.; Sams, A.; Singh, M. Algi-Matrix Based 3D Cell Culture System as an In-Vitro Tumor Model for Anticancer Studies PLoS One 2013, 8 (1) e53708
49. Sarkar, B.; Dosch, J.; Simeone, D. M. Cancer Stem Cells: A New Theory Regarding a Timeless Disease Chem. Rev. 2009, 109, 3200-3208
50. Johnson, A. W.; Hraley, B. Cell Death Signaling and Anticancer Therapy Anticancer Res. 2011, 31, 3237-3247
51. Weigelt, B.; Bissell, M. J. Unraveling the Micro-Environmental Influences on The Normal Mammary Gland and Breast Cancer Semin Cancer Biol. 2008, 18, 311-321
52. Wang, N.; Wang, X.; Xing, C.; Sun, B.; Yu, X.; Hu, J.; Liu, J.; Zeng, M.; Xiong, M.; Zhou, S.; Yang, J. Role of TGF-beta1 in Bone Matrix Production in Vascular Smooth Muscle Cells Induced by a High-Phosphate environment Nephron 2010, 115, e60-68
53. Magnusson, P.; Larsson, L.; Englund, G.; Larsson, B.; Lena, S. S.; Peter, S. Differences of Bone Alkaline Phosphatase Isoforms in Metastatic Bone Disease and Discrepant Effects of Clodronate on Different Skeletal Sites Indicated by the Location of Pain Clin. Chem. 1998, 44, 1621-1628
54. Fantozzi, A.; Gruber, D. C.; Pisarsky, L.; Heck, C.; Kunita, A.; Yilmaz, M.; Meyer-Schaller, N.; Cornille, K.; Hopfer, U.; Bentires-Alj, M.; Christofori, G. VEGF-Mediated Angiogenesis Links Emt-Induced Cancer Stamens to Tumor Initiation Cancer Res. 2014, 1, 1566-1575
55. Ma, J.; Waxman, D. J. Combination of Anti-Angiogenesis with Chemotherapy for More Effective Cancer Treatment Mol. Cancer 2008, 7, 3670-3684
56. Zhao, Y.; Butler, E. B.; Tan, M. Targeting Cellular Metabolism to Improve Cancer Therapeutics Cell Death Dis. 2013, 4, e532